Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 12, 2012 - Issue 4
Submit an article Journal homepage
139
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

Clinical and economic review of erlotinib in non-small-cell lung cancer

Kai Yeung Pharmaceutical Outcomes Research and Policy Program, University of Washington, 1959 NE Pacific Avenue, H-375I, Box 357630, Seattle, WA 98195-7630, USA
&
Josh J Carlson Pharmaceutical Outcomes Research and Policy Program, University of Washington, 1959 NE Pacific Avenue, H-375I, Box 357630, Seattle, WA 98195-7630, USA. [email protected]
Pages 411-423 | Published online: 09 Jan 2014

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lovisa Lundholm, Petra Hååg, Therese Juntti, Rolf Lewensohn & Kristina Viktorsson. (2014) Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells. International Journal of Radiation Biology 90:8, pages 718-726.
Read now
Liu Hong, Yu Han & Lubi Brain. (2013) Epidermal growth factor receptor: an important target in esophageal cancer. Expert Opinion on Therapeutic Targets 17:10, pages 1179-1185.
Read now

Articles from other publishers (6)

Yaling Zhang, Lili Wang, Baoli Sun, Xiabing Li, Qiaoli Hou, Wei Wang & Baolin Li. (2020) Synthesis and Antiproliferative Activities of Novel Substituted 5‐Anilino‐ α ‐Glucofuranose Derivatives . Chemistry & Biodiversity 17:4.
Crossref
Hogir Salim, Dali Zong, Petra Hååg, Metka Novak, Birgitta Mörk, Rolf Lewensohn, Lovisa Lundholm & Kristina Viktorsson. (2015) DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines. BMC Cancer 15:1.
Crossref
Ruiguang Zhang, Yan Li, Zhongliang Wang, Lingjuan Chen, Xiaorong Dong & Xiu Nie. (2015) Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis. Tumor Biology 36:11, pages 8585-8592.
Crossref
Fabrice Smieliauskas, Chun-Ru Chien, Chan Shen, Daniel M. Geynisman & Ya-Chen Tina Shih. (2014) Cost-Effectiveness Analyses of Targeted Oral Anti-Cancer Drugs: A Systematic Review. PharmacoEconomics 32:7, pages 651-680.
Crossref
Fang-Han Hsu & Erchin Serpedin. (2014) Investigating effects of copy number alterations on targeted therapy response using a conditioning-based model. Investigating effects of copy number alterations on targeted therapy response using a conditioning-based model.
Fang-Han Hsu, Edward R. Dougherty, Yidong Chen & Erchin Serpedin. (2013) Estimating Conditional Probabilities for the Detection of Unfavorable Copy Number Alterations in a Targeted Therapy. IEEE Transactions on Biomedical Engineering 60:10, pages 2933-2942.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.